Source of oncofetal ED-B-containing fibronectin: Implications of production of both tumor and endothelial cells

Cancer Research

Volumn 60, Issue 1, 2000, Pages 164-169

  Midulla, Marta ^a   Verma, Rakesh ^a,b   Pignatelli, Massimo ^a   Ritter, Mary A ^a   Courtenay Luck, Nigel S ^a,b   George, Andrew J T ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b Antisoma plc   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN;

ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; COLORECTAL CARCINOMA; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; TUMOR XENOGRAFT;

ADULT; ANIMALS; BREAST NEOPLASMS; CELL LINE, TRANSFORMED; COLON; COLONIC NEOPLASMS; FIBRONECTINS; HT29 CELLS; HUMANS; MICE; NEOPLASM PROTEINS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0033983271     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Alitalo, K., and Vaheri, A. Pericellular matrix in malignant transformation. Adv. Cancer Res., 37: 111-150, 1982.
2. Hynes, R. O., and Yamada, K. M. Fibronectins: multifunctional modular glycoproteins. J. Cell Biol., 95: 369-377, 1982.
3. Zardi, L., Carnemolla, B., Siri, A., Petersen, T. E., Paolella, G., Sebastio, G., and Baralle, F. E. Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J., 6: 2337-2342, 1987.
4. Schwarzbauer, J. E., Tamkun, J. W., Lemischka, I. R., and Hynes, R. O. Three different fibronectin mRNAs arise by alternative splicing within the coding region. Cell, 35: 421-431, 1983.
5. Kornblihtt, A. R., Vibe-Pedersen, K., and Baralle, F. E. Human fibronectin: molecular cloning evidence for two mRNA species differing by an internal segment coding for a structural domain. EMBO J., 3: 221-226, 1984.
6. Kornblihtt, A. R., Vibe-Pedersen, K., and Baralle, F. E. Human fibronectin: cell specific alternative mRNA splicing generates polypeptide chains differing in the number of internal repeats. Nucleic Acids Res., 12: 5853-5868, 1984.
7. Tamkun, J. W., Schwarzbauer, J. E., and Hynes, R. O. A single rat fibronectin gene generates three different mRNAs by alternative splicing of a complex exon. Proc. Natl. Acad. Sci. USA, 81: 5140-5144, 1984.
8. Kornblihtt, A. R., Umezawa, K., Vibe-Pedersen, K., and Baralle, F. E. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J., 4: 1755-1759, 1985.
9. Gutman, A., and Kornblihtt, A. R. Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc. Natl. Acad. Sci. USA, 84: 7179-7182, 1987.
10. Schwarzbauer, J. E., Patel, R. S., Fonda, D., and Hynes, R. O. Multiple sites of alternative splicing of the rat fibronectin gene transcript. EMBO J., 6: 2573-2580, 1987.
11. Castellani, P., Siri, A., Rosellini, C., Infusini, E., Borsi, L., and Zardi, L. Transformed human cells release different fibronectin variants than do normal cells. J. Cell Biol., 103: 1671-1677, 1986.
12. Borsi, L., Carnemolla, B., Castellani, P., Rosellini, C., Vecchio, D., Allemanni, G., Chang, S. E., Taylor-Papadimitriou, J., Pande, H., and Zardi, L. Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J. Cell Biol., 104: 595-600, 1987.
13. Camemolla, B., Balza, E., Siri, A., Zardi, L., Nicotra, M. R., Bigotti, A., and Natali, P. G. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J. Cell Biol., 108, 1139-1148, 1989.
14. Oyama, F., Hirohashi, S., Shimosato, Y., Titani, K., and Sekiguchi, K. Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors. J. Biol. Chem., 264: 10331-10334, 1989.
15. Oyama, F., Hirohashi, S., Shimosato, Y., Titani, K., and Sekiguchi, K. Oncodevelopmental regulation of the alternative splicing of fibronectin pre-messenger RNA in human lung tissues. Cancer Res., 50: 1075-1078, 1990.
16. Borsi, L., Balza, E., Allemanni, G., and Zardi, L. Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues. Exp. Cell. Res., 199: 98-105, 1992.
17. Kaczmarek, J., Castellani, P., Nicolo, G., Spina, B., Allemanni, G., and Zardi, L. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int. J. Cancer, 58: 11-16, 1994.
18. Castellani, P., Viale, G., Dorcaratto, A., Nicolo, G., Kaczmarek, J., Querze, G., and Zardi, L. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int. J. Cancer, 59: 612-618, 1994.
19. Pujuguet, P., Hammann, A., Moutet, M., Samuel, L., Martin, F., and Martin, M. Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Am. J. Pathol., 148: 579-592, 1996.
20. Fogh, J., and Trempe, G. New human tumor cell lines. In: J. Fogh (ed.). Human Tumor Cell Lines in Vitro, pp. 115-159. New York: Plenum Press, 1975.
21. Eagle, H. Propagation in a fluid medium of a human epidermoid carcinoma, strain KB. Proc. Soc. Exp. Biol. Med., 89: 362-364, 1955.
22. Brooks, S. C., Locke, E. R., and Soule, H. D. Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J. Biol. Chem., 248: 6251-6253, 1973.
23. Jaffe, E. A., Nachman, R. L., Becker, C. G., and Minick, C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Investig., 52: 2745-2756, 1973.
24. Takahasi, K., Sawasaki, Y., Hata, J., Mukai, K., and Goto, T. Spontaneous transformation and immortalization of human endothelial cells. In Vitro Cell Dev. Biol., 26: 265-274, 1990.
25. Edgell, C-J. S., McDonald, C. C., and Graham, J. B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. USA, 80: 3734-3737, 1983.
26. Carnemolla, B., Leprini, A., Allemanni, G., Saginati, M., and Zardi, L. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. J. Biol. Chem., 267: 24689-24692, 1992.
27. Carnemolla, B., Neri, D., Castellani, P., Leprini, A., Neri, G., Pini, A., Winter, G., and Zardi, L. Phage antibodies with pan-species recognition of the oncofetal angiogenesis marker fibronectin ED-B domain. Int. J. Cancer, 68: 397-405, 1996.
28. Mariani, G., Lasku, A., Pau, A., Villa, G., Motta, C., Calgano, G., Taddei, G. Z., Castellani, P., Syrigos, K., Dorcaratto, A., Epenetos, A. A., Zardi, L., and Viale, G. A. A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumors. Cancer (Phila.), 80 (Suppl. 12): 2484-2489, 1997.
29. Verma, R., George, A. J. T., and Courtenay-Luck, N. S. Generation of a single-chain Fv (sFv) against an oncofetal antigen associated with tumorigenesis and angiogenesis. J. Int. Soc. Tumor Targeting, 1: 9-21, 1999.
30. Chen, W., and Culp, L. A. Adhesion mediated by fibronectin's alternatively spliced EDb (EIIIB) and its neighboring type III repeats. Exp. Cell Res., 223: 9-19, 1996.
31. Hashimoto-Uoshima, M., Yan, Y. Z., Schneider, G., and Aukhil, I. The alternatively spliced domains EIIIB and EIIIA of human fibronectin affect cell adhesion and spreading. J. Cell Sci., 110: 2271-2280, 1997.